The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124329433 12432943 3 F 20160428 20160711 20160603 20160720 EXP PHEH2016US013630 SANDOZ 60.60 YR M Y 0.00000 20160720 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124329433 12432943 1 SS GILENYA FINGOLIMOD HYDROCHLORIDE 1 Unknown UNK, QOD 0 CAPSULE
124329433 12432943 2 SS GILENYA FINGOLIMOD HYDROCHLORIDE 1 Unknown UNK, QOD 0 CAPSULE
124329433 12432943 3 PS GABAPENTIN. GABAPENTIN 1 Unknown 300 MG, BID (TOOK 600 MG AT BEDTIME) 75539 300 MG BID
124329433 12432943 4 SS GABAPENTIN. GABAPENTIN 1 Unknown 900 MG, UNK 75539 900 MG
124329433 12432943 5 C VITAMIN D CHOLECALCIFEROL 1 Unknown 10000 IU, QD U 0 10000 IU QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124329433 12432943 1 Product used for unknown indication
124329433 12432943 3 Product used for unknown indication
124329433 12432943 5 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
124329433 12432943 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124329433 12432943 Abdominal discomfort
124329433 12432943 Aphasia
124329433 12432943 Burning sensation
124329433 12432943 Crohn's disease
124329433 12432943 Decreased appetite
124329433 12432943 Decreased vibratory sense
124329433 12432943 Diarrhoea
124329433 12432943 Dizziness
124329433 12432943 Drug intolerance
124329433 12432943 Fatigue
124329433 12432943 Feeling abnormal
124329433 12432943 Grip strength decreased
124329433 12432943 Headache
124329433 12432943 Hyperreflexia
124329433 12432943 Hypotonia
124329433 12432943 Limb discomfort
124329433 12432943 Muscle spasms
124329433 12432943 Muscle spasticity
124329433 12432943 Muscle tightness
124329433 12432943 Musculoskeletal stiffness
124329433 12432943 Nausea
124329433 12432943 Pain
124329433 12432943 Paraesthesia
124329433 12432943 Prescribed underdose
124329433 12432943 Somnolence
124329433 12432943 Stress
124329433 12432943 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124329433 12432943 1 20151204 0